Expert Opinion on Pharmacotherapy, Volume 14, Issue 16 (2013)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Pharmacotherapy, Volume 14, Issue 16 (2013)

See all volumes and issues
Vol 25, 2024 Vol 24, 2023 Vol 23, 2022 Vol 22, 2021 Vol 21, 2020 Vol 20, 2019 Vol 19, 2018 Vol 18, 2017 Vol 17, 2016 Vol 16, 2015 Vol 15, 2014 Volume 14, 2013 Vol 13, 2012 Vol 12, 2011 Vol 11, 2010 Vol 10, 2009 Vol 9, 2008 Vol 8, 2007 Vol 7, 2006 Vol 6, 2005 Vol 5, 2004 Vol 4, 2003 Vol 3, 2002 Vol 2, 2001 Vol 1, 1999-2000
Download citations Download PDFs Download issue

Editorial

Editorial
Alcohol addiction: toward a patient-oriented pharmacological treatment
Giovanni Addolorato MD, Antonio Mirijello MD & Lorenzo Leggio MD PhD MSc
Pages: 2157-2160
Published online: 29 Aug 2013
AbstractforAlcohol addiction: toward a patient-oriented pharmacological treatment | Full Text | References | PDF (225.2 KB)
  • 1080 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access

Original Research

Article
Effects of canrenone in patients with metabolic syndrome
Giuseppe Derosa MD PhD, Aldo Bonaventura MD, Lucio Bianchi MD, Davide Romano MD, Angela D'Angelo BD PhD, Elena Fogari MD & Pamela Maffioli MD
Pages: 2161-2169
Published online: 28 Aug 2013
AbstractforEffects of canrenone in patients with metabolic syndrome | Full Text | References | PDF (298.3 KB)
  • 150 Views
  • 14 CrossRef citations
  • 0Altmetric

Reviews

Review Article
Clinical investigation of receptor and non-receptor tyrosine kinase inhibitors for the treatment of epithelial ovarian cancer
Samuel J Klempner, Andrea P Myers, Gordon B Mills & Shannon N Westin MD MPH
Pages: 2171-2182
Published online: 12 Aug 2013
AbstractforClinical investigation of receptor and non-receptor tyrosine kinase inhibitors for the treatment of epithelial ovarian cancer | Full Text | References | PDF (525 KB)
  • 239 Views
  • 14 CrossRef citations
  • 0Altmetric
Review Article
Chemotherapy for osteosarcoma – Where does it come from? What is it? Where is it going?
Norio Yamamoto MD PhD & Hiroyuki Tsuchiya MD PhD
Pages: 2183-2193
Published online: 07 Aug 2013
AbstractforChemotherapy for osteosarcoma – Where does it come from? What is it? Where is it going? | Full Text | References | PDF (352.8 KB)
  • 417 Views
  • 37 CrossRef citations
  • 0Altmetric
Review Article
Protein kinase inhibitors in melanoma
Thomas K Eigentler, Friedegund Meier & Claus Garbe
Pages: 2195-2201
Published online: 31 Aug 2013
AbstractforProtein kinase inhibitors in melanoma | Full Text | References | PDF (265.3 KB)
  • 329 Views
  • 9 CrossRef citations
  • 0Altmetric
Review Article
Protein kinase inhibitors in metastatic colorectal cancer. Let's pick patients, tumors, and kinase inhibitors to piece the puzzle together!
Sebastian Stintzing & Heinz-Josef Lenz
Pages: 2203-2220
Published online: 13 Aug 2013
AbstractforProtein kinase inhibitors in metastatic colorectal cancer. Let's pick patients, tumors, and kinase inhibitors to piece the puzzle together! | Full Text | References | PDF (858.1 KB)
  • 175 Views
  • 4 CrossRef citations
  • 0Altmetric
Review Article
Targeting angiogenesis in renal cell carcinoma
Edwin M Posadas MD FACP, Suwicha Limvorasak, Shaleekha Sharma & Robert A Figlin
Pages: 2221-2236
Published online: 28 Aug 2013
AbstractforTargeting angiogenesis in renal cell carcinoma | Full Text | References | PDF (504.6 KB)
  • 520 Views
  • 30 CrossRef citations
  • 0Altmetric
Review Article
Agonists of luteinizing hormone-releasing hormone in prostate cancer
Ferenc G Rick MD PhD, Norman L Block MD FACS & Andrew V Schally PhD MDhc DSc(Multi)
Pages: 2237-2247
Published online: 28 Aug 2013
AbstractforAgonists of luteinizing hormone-releasing hormone in prostate cancer | Full Text | References | PDF (379.6 KB)
  • 504 Views
  • 17 CrossRef citations
  • 0Altmetric

Drug Evaluations

Azilsartan medoxomil in the treatment of hypertension: the definitive angiotensin receptor blocker?
Vivencio Barrios MD PhD & Carlos Escobar MD PhD
Pages: 2249-2261
Published online: 26 Sep 2013
Abstractfor Azilsartan medoxomil in the treatment of hypertension: the definitive angiotensin receptor blocker? | Full Text | References | PDF (542.6 KB)
  • 609 Views
  • 5 CrossRef citations
  • 0Altmetric
An old drug with a new future: bendamustine in multiple myeloma
Massimo Gentile, Anna Grazia Recchia, Carla Mazzone, Ernesto Vigna, Massimo Martino, Lucio Morabito, Eugenio Lucia, Sabrina Bossio, Laura De Stefano, Teresa Granata, Angela Palummo & Fortunato Morabito
Pages: 2263-2280
Published online: 21 Sep 2013
AbstractforAn old drug with a new future: bendamustine in multiple myeloma | Full Text | References | PDF (517.5 KB)
  • 697 Views
  • 13 CrossRef citations
  • 0Altmetric
Pharmacological profile, efficacy and safety of lixisenatide in type 2 diabetes mellitus
Thomas Forst & Andreas Pfützner
Pages: 2281-2296
Published online: 03 Oct 2013
AbstractforPharmacological profile, efficacy and safety of lixisenatide in type 2 diabetes mellitus | Full Text | References | PDF (660.8 KB)
  • 2073 Views
  • 21 CrossRef citations
  • 0Altmetric
Free Access
Tramadol and acetaminophen combination for chronic non-cancer pain
Paul Farquhar-Smith MB BChir MA FRCA PhD FFICM FFPMRCA & Anthony Gubbay MB ChB BSc FRCA
Pages: 2297-2304
Published online: 26 Sep 2013
Abstractfor Tramadol and acetaminophen combination for chronic non-cancer pain | Full Text | References | PDF (355.4 KB)
  • 641 Views
  • 7 CrossRef citations
  • 0Altmetric

Correspondence

Article
A potential use for injectable oxygen microparticles in anaphylaxis
Sanjay Budhdeo BA BMBCh, Chathika Weerasuriya BA MBBChir & Vivek Rajagopal MBBS MD MRCP
Pages: 2305-2306
Published online: 18 Sep 2013
CitationforA potential use for injectable oxygen microparticles in anaphylaxis | Full Text | References | PDF (196.1 KB)
  • 78 Views
  • 0 CrossRef citations
  • 0Altmetric

Research Article

Article
Related articles
Page: i
Published online: 09 Oct 2013
CitationforRelated articles | Full Text | PDF (169.2 KB)
  • 40 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles